In addition, a SIRT6 inhibitor with quinazolinedione structure (named 1) was administered to mice in an in vivo study of SIRT6 inhibition for treating type 2 diabetes [14]. The gene discussed is SIRT6; the disease is type 2 diabetes mellitus.